Jan 27 (Reuters) - Quantum Genomics SA ALQGC.PA :
* Launches 9.1 million euro ($10.2 million) capital increase
on Alternext Paris
* Capital increase to finance clinical studies of phase IIa
on QGC001 drug candidate
* Shareholders can subscribe to new shares from Jan. 27 to
Feb. 12 for maximum amount of 5 million euros
* Indicative price range is 5.40 euros to 6.30 euros per
share
* 1,550,000 new shares to be issued, increased to maximum
1,782,500 shares in case of extension clause and up to 2,049,875
shares in case of over-allotment option
Source text for Eikon: ID:nACT38597
Further company coverage: ALQGC.PA
($1 = 0.8906 euros)
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 698 3920;))
Keywords: QUANTUM GENOMICS/BRIEF